Integrity of E3 ubiquitin ligase complex as a biomarker of response to treatment with immunomodulatory drugs in patients with multiple myeloma.
2014/13/B/NZ5/03160
Keywords
Descriptors
- NZ5_3: Patogeneza chorób człowieka
- NZ5_7: Leczenie chorób człowieka
- NZ5_9: Inne zagadnienia pokrewne
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Hematologii i Transfuzjologii
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 5
Call
OPUS 7 – announced on 2014-03-17
- Amount awarded
- 403 084 PLN
- Project start date
- 2015-02-25
- Project end date
- 2018-02-24
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Information in the final report
Publication in academic press/journals (1)
-
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
- Authors:
- Joanna Barankiewicz; Anna Szumera-Ciećkiewicz; Aleksander Salomon-Perzyński; Paulina Wieszczy; Agata Malenda; Filip Garbicz; Monika Prochorec-Sobieszek; Irena Misiewicz-Krzemińska; Przemysław Juszczyński; Ewa Lech-Marańda
- Academic press:
- Jounral of Clinical Medicine (year: 2021, volume: 10, pages: 10(12):2683.), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/jcm10122683 – link to the publication
Articles in post-conference publications (1)
-
EXPRESSION SIGNIFICANCE OF CRL4-CRBN PROTEINS COMPLEX IN MULTIPLE MYELOMA PATIENTS TREATED WITH IMMUNOMODULATORY DRUGS.
- Authors:
- Joanna Barankiewicz, Agata Malenda, Filip Garbicz, Anna Szumera-Ciećkiewicz, Monika Prochorec-Sobieszek, Przemysław Juszczyński, Ewa Lech-Marańda
- Conference:
- European Hematology Association Virtual Congress (year: 2020, pages: 294834), Publisher: EHA Library
- Date:
- conference 18.06 - 15.08.2020
- Status:
- Published